ChartSpan, a prominent provider of care management services, has announced its acquisition of Validic, a leading personal health data platform. This strategic merger aims to redefine remote healthcare by integrating specialized clinical services with an extensive digital health data infrastructure. The unified company, operating under the ChartSpan name, is set to deliver a new standard in data-driven, proactive patient care.
A Strategic Union for Proactive Healthcare
The combination of ChartSpan's clinical expertise and Validic's technology creates a powerful entity for managing remote health programs. This synergy will power services like Chronic Care Management and Remote Patient Monitoring by transforming patient-generated data into actionable clinical insights. The goal is to enable a continuous understanding of patient health, moving beyond periodic clinical snapshots.
Christine Hawkins, CEO of ChartSpan, emphasized that this partnership will help healthcare organizations identify risks and intervene sooner. Drew Schiller, CEO of Validic, echoed this sentiment, noting the merger combines continuous patient insight with proven clinical services. Together, they aim to leverage data from beyond clinic walls to personalize interventions and improve population health outcomes.
Redefining Remote Patient Monitoring
A key outcome of this acquisition is a new, integrated offering that combines Chronic Care Management (CCM) with Remote Patient Monitoring (RPM). This model closes the data gap that often exists between monthly patient appointments by utilizing a constant stream of biomedical device data. This approach transforms routine patient outreach into a continuously informed clinical experience for more proactive care.
For healthcare providers, this unified service is designed to increase revenue while simultaneously reducing the total cost of care. By enabling early intervention, the program helps prevent costly emergency room visits and hospitalizations. Patients benefit from a seamless experience, receiving enhanced monitoring from the same trusted clinical team they already know.
Expanding Market Reach and Product Offerings
The acquisition significantly broadens ChartSpan's market reach beyond its traditional care management clientele. The company will now offer Validic's established product lines, including its health data API infrastructure, RPM software, and device logistics support. This expanded portfolio will serve a wider audience of health systems, digital health companies, payers, and life sciences organizations.
This diverse product suite provides ChartSpan with the flexibility to meet clients at any stage of their remote care journey. Organizations can now choose a complete clinical services partner, a flexible data infrastructure to power their own programs, or a logistics backbone for at-home connected care. This adaptability positions ChartSpan as a comprehensive solution provider in the evolving digital health landscape.
The Future of Data-Driven Care
The transaction, for which Oppenheimer & Co. Inc. served as financial advisor to Validic, marks a significant step forward in connected healthcare. Financing for ChartSpan was led by BIP Capital, signaling strong investor confidence in the combined company's vision. This strategic backing will fuel the integration and development of new, innovative solutions for proactive and personalized care.
Ultimately, ChartSpan's acquisition of Validic establishes a new leader in the clinical services and infrastructure space for data-driven healthcare. By uniting continuous patient visibility with expert clinical action, the company is poised to improve health outcomes and lower costs at scale. This merger represents a foundational shift toward a more predictive and personalized future for remote patient management.